Clonixin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H11ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V7DXN0M42R, chemically known as 3-pyridinecarboxylic acid, 2-((3-chloro-2-methylphenyl)amino)- but generally known as clonixin, which bears US NIH Compound Identifier 28718. European Medicines Agency schedules Clonixin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06734MIG. The term CLONIXIN is an International Non-Proprietary Name. CLONIXIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clonixin under HS 29333999 and SITC 51574. As of Q4 2014, CLONIXIN remains the US FDA Preferred Term for this commodity. Clonixin bears US NLM identifiers UMLS ID C0009018 and NCI Concept Code C65340. SMILES: CLC1C(C(NC2NCCCC2C(=O)O)CCC1)C.